AU3760593A - Vaccine for preventing HIV-infected disease and production thereof - Google Patents

Vaccine for preventing HIV-infected disease and production thereof

Info

Publication number
AU3760593A
AU3760593A AU37605/93A AU3760593A AU3760593A AU 3760593 A AU3760593 A AU 3760593A AU 37605/93 A AU37605/93 A AU 37605/93A AU 3760593 A AU3760593 A AU 3760593A AU 3760593 A AU3760593 A AU 3760593A
Authority
AU
Australia
Prior art keywords
vaccine
production
preventing hiv
infected disease
infected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37605/93A
Other languages
English (en)
Inventor
Kenji Okuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inmel Co Ltd
Original Assignee
Inmel Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inmel Co Ltd filed Critical Inmel Co Ltd
Publication of AU3760593A publication Critical patent/AU3760593A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU37605/93A 1992-03-26 1993-03-19 Vaccine for preventing HIV-infected disease and production thereof Abandoned AU3760593A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP4-98602 1992-03-26
JP9860292 1992-03-26
JP23764892 1992-08-14
JP4-237648 1992-08-14
JP5054239A JPH0748276A (ja) 1992-03-26 1993-03-15 Ｈｉｖ感染症予防ワクチンおよびその製造法
JP5-54239 1993-03-15

Publications (1)

Publication Number Publication Date
AU3760593A true AU3760593A (en) 1993-10-21

Family

ID=27295215

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37605/93A Abandoned AU3760593A (en) 1992-03-26 1993-03-19 Vaccine for preventing HIV-infected disease and production thereof

Country Status (3)

Country Link
JP (1) JPH0748276A (ja)
AU (1) AU3760593A (ja)
WO (1) WO1993018791A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2959642T3 (es) * 2015-05-13 2024-02-27 The Us Secretary Of The Department Of Health And Human Services Metodos y composiciones para inducir una respuesta inmunitaria mediante construcciones con elementos conservados

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8629116D0 (en) * 1986-12-05 1987-01-14 Hoffmann La Roche Env/gag polypeptides
WO1988005440A1 (fr) * 1987-01-16 1988-07-28 Institut Pasteur Peptides ayant des proprietes immunologiques 2-hiv-2
DE3853779T2 (de) * 1987-05-29 1995-09-07 Baylor College Medicine Hiv-1 neutralisierende monoklonale antikörper.
JPH01179687A (ja) * 1987-12-30 1989-07-17 Chemo Sero Therapeut Res Inst Ｈｉｖ融合蛋白質
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
GB8910145D0 (en) * 1989-05-03 1989-06-21 Connaught Lab Synthetic peptides for an hiv-1 vaccine

Also Published As

Publication number Publication date
JPH0748276A (ja) 1995-02-21
WO1993018791A1 (en) 1993-09-30

Similar Documents

Publication Publication Date Title
AU656157B2 (en) Pharmaceutical agents
AU3888793A (en) Novel medicament
AU3688393A (en) Surgical fastener
AU5681294A (en) Tastemasked pharmaceutical materials
AU3570193A (en) Altered antibodies, products and processes relating thereto
AU8055594A (en) Process for producing simvastatin and analogs thereof
AU6784490A (en) Pharmaceuticals
AU5342290A (en) Cd8-based pharmaceuticals
AU3720193A (en) Hydroisoindolines and hydroisoquinolines as psychotropic drugs
AU5449590A (en) Anti-hiv drug
AU8072691A (en) Pharmaceutical preparations
HU9300804D0 (en) Pharmaceutical preparatives
AU3263493A (en) Tonometer
AU4918790A (en) Medicament
AU7719791A (en) Therapeutic product
AU5737494A (en) Human thrombospondin-4
AU4172693A (en) Novel thienothiazine derivatives, process for their preparation and their use
AU5611894A (en) Extended duration antacid product
AU7294491A (en) Labdanes and process for their preparation
AU2493792A (en) Pharmaceutical preparation
AU3760593A (en) Vaccine for preventing HIV-infected disease and production thereof
CZ87895A3 (en) Pharmaceutical preparation
AU3404293A (en) Novel substituted stannosilicates and preparation thereof
AU6236090A (en) Pharmaceutical preparations
AU4379893A (en) Oral decongestant product